As of 2026-01-04, the Relative Valuation of Regenxbio Inc (RGNX) is (76.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.57 USD, the upside of Regenxbio Inc based on Relative Valuation is -660.1%.
The range of the Relative Valuation is (63.62) - (88.57) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 25.2x | 21.5x |
| Forward P/E multiples | 18.1x - 25.4x | 21.8x |
| Fair Price | (63.62) - (88.57) | (76.01) |
| Upside | -568.8% - -752.7% | -660.1% |
| Date | P/E |
| 2026-01-02 | -3.86 |
| 2025-12-31 | -4.10 |
| 2025-12-30 | -4.01 |
| 2025-12-29 | -4.07 |
| 2025-12-26 | -4.03 |
| 2025-12-24 | -4.11 |
| 2025-12-23 | -4.08 |
| 2025-12-22 | -4.26 |
| 2025-12-19 | -4.15 |
| 2025-12-18 | -3.84 |
| 2025-12-17 | -3.75 |
| 2025-12-16 | -4.01 |
| 2025-12-15 | -3.93 |
| 2025-12-12 | -3.95 |
| 2025-12-11 | -3.66 |
| 2025-12-10 | -3.72 |
| 2025-12-09 | -3.62 |
| 2025-12-08 | -3.77 |
| 2025-12-05 | -3.74 |
| 2025-12-04 | -3.69 |
| 2025-12-03 | -3.66 |
| 2025-12-02 | -3.47 |
| 2025-12-01 | -3.58 |
| 2025-11-28 | -3.81 |
| 2025-11-26 | -3.77 |
| 2025-11-25 | -3.83 |
| 2025-11-24 | -3.48 |
| 2025-11-21 | -3.36 |
| 2025-11-20 | -3.09 |
| 2025-11-19 | -3.11 |
| 2025-11-18 | -3.20 |
| 2025-11-17 | -3.17 |
| 2025-11-14 | -3.27 |
| 2025-11-13 | -3.31 |
| 2025-11-12 | -3.30 |
| 2025-11-11 | -3.29 |
| 2025-11-10 | -3.14 |
| 2025-11-07 | -3.19 |
| 2025-11-06 | -3.18 |
| 2025-11-05 | -3.30 |
| 2025-11-04 | -3.29 |
| 2025-11-03 | -3.41 |
| 2025-10-31 | -3.63 |
| 2025-10-30 | -3.65 |
| 2025-10-29 | -3.65 |
| 2025-10-28 | -3.74 |
| 2025-10-27 | -3.88 |
| 2025-10-24 | -3.71 |
| 2025-10-23 | -3.58 |
| 2025-10-22 | -3.47 |